查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1599521

穿戴式人工腎臟市場：按階段、透析類型和最終用戶 - 2025-2030 年全球預測

Wearable Artificial Kidney Market by Disease Stage (Acute Renal Disease, End-Stage Renal Disease), Dialysis Type (Hemodialysis, Peritoneal Dialysis), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年穿戴式人工腎臟市場價值為1.8019億美元，預計2024年將達到2.1308億美元，複合年成長率為18.74%，到2030年將達到5.9978億美元。

穿戴式人工腎臟 (WAK) 是一項醫療創新，旨在為慢性腎臟病(CKD) 患者提供傳統臨床環境以外的腎臟替代治療。該治療裝置旨在提高生活品質，提供連續透析治療，與傳統透析方法相比具有更大的機動性和靈活性。由於老化、糖尿病和高血壓等因素，全球 CKD 盛行率不斷增加，因此對 WAK 的需求源自於此。除了生命維持之外，WAK 還有可能減少與傳統透析相關的併發症，例如感染風險和心血管問題。主要的最終使用場景包括居家醫療、門診診所以及偏遠和服務不足的地區，提供了巨大的市場範圍。公共和私人醫療保健支出的增加、小型化和生物相容性技術的進步是推動市場興趣的關鍵成長要素。新的商機在於個人化治療、與遠端醫療服務整合以及與保險公司合作讓 WAK 更容易獲得。然而，其局限性包括高昂的研發成本、監管挑戰以及需要大規模臨床試驗來確定安全性和有效性。進一步的挑戰包括高昂的實施成本以及與現有醫療保健基礎設施的複雜整合。研究創新應著重於延長電池壽命、小型化和提高生物相容性。生物材料和過濾效率的研究是突破技術界限的一個有前景的領域。此外，探索人工智慧主導的監測系統，為個人化患者照護提供預測分析，可以提供競爭優勢。市場的本質是動態和競爭的，需要採取多學科方法來解決臨床、技術和商業性障礙。公司應專注於與高科技公司和臨床組織的合作，以最佳化產品開發並擴大其市場足跡，同時解決創新和監管合規問題。

主要市場統計
基準年[2023] 18019萬美元
預測年份 [2024] 21308萬美元
預測年份 [2030] 5.9978 億美元
複合年成長率（%） 18.74%

市場動態：揭示快速發展的穿戴式人工腎臟市場的關鍵市場洞察

穿戴式人工腎臟市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 糖尿病和高血壓的盛行率增加
    • 由於捐贈者短缺而限制移植
    • 人們對各種腎衰竭疾病和不健康生活方式的認知不斷提高
  • 市場限制因素
    • 透析產品嚴格監管政策
  • 市場機會
    • 人工腎臟的技術進展
    • 提高患者選擇門診透析的意識
  • 市場挑戰
    • 使用人工腎臟的併發症風險

波特五力：駕馭穿戴式人工腎臟市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對穿戴式人工腎臟市場的影響

外部宏觀環境因素在塑造穿戴式人工腎臟市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解穿戴式人工腎臟市場的競爭狀況

對穿戴式人工腎臟市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣穿戴式人工腎臟市場供應商績效評估

FPNV 定位矩陣是評估穿戴式人工腎臟市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了穿戴式人工腎臟市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，穿戴式人工腎臟市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 糖尿病和高血壓的增加
      • 由於缺乏捐贈者，移植受到限制
      • 人們對各種腎衰竭疾病和不健康生活方式的認知不斷提高
    • 抑制因素
      • 透析產品嚴格監管政策
    • 機會
      • 人工腎臟的技術進步
      • 提高患者選擇門診透析的意識
    • 任務
      • 與使用人工腎臟相關的併發症的風險
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章依疾病階段分類的穿戴式人工腎臟市場

  • 急性腎臟病
  • 末期腎病

第7章穿戴式人工腎臟市場（依透析類型）

  • 血液透析機
  • 腹膜透析

第8章穿戴式人工腎臟市場：依最終用戶分類

  • 門診手術中心
  • 透析中心
  • 醫院

第9章 北美及南美穿戴式人工腎臟市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太穿戴式人工腎臟市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東、非洲穿戴式人工腎臟市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • ANSELL LTD
  • Asahi Kasei Medical Co., Ltd.
  • AWAK Technologies
  • B. Braun
  • Baxter International Inc.
  • Blood Purification Technologies Inc.
  • Cardinal Health, Inc.
  • Dynarex Corporation
  • GE Healthcare
  • Glove Corporation Bhd
  • Hartalega Holdings
  • Hitachi Medical Corporation
  • KAWASUMI LABORATORIES, INC
  • Koninklijke Philips NV
  • Nanodialysis BV
  • Semperit AG Holding
  • Siemens AG
  • Triomed AB
Product Code: MRR-221461476D86

The Wearable Artificial Kidney Market was valued at USD 180.19 million in 2023, expected to reach USD 213.08 million in 2024, and is projected to grow at a CAGR of 18.74%, to USD 599.78 million by 2030.

The Wearable Artificial Kidney (WAK) is a transformative healthcare innovation designed to provide renal replacement therapy for patients with chronic kidney disease (CKD) outside the traditional clinical settings. This device aims to offer continuous dialysis treatment, enhancing quality of life through greater mobility and flexibility compared to conventional dialysis methods. The necessity of WAKs stems from the growing prevalence of CKD globally, driven by factors such as aging populations, diabetes, and hypertension. Its applications extend beyond life support, potentially reducing complications associated with traditional dialysis, such as infection risks and cardiovascular issues. Key end-use scenarios include home care, outpatient clinics, and remote or underserved areas, providing a significant market scope. The rising public and private healthcare expenditures and advancements in miniaturization and biocompatibility technologies are critical growth factors, helping drive market interest. Emerging opportunities lie in the personalization of treatments, integration with telehealth services, and partnerships with insurance providers to make WAK more accessible. However, limitations include high R&D costs, regulatory challenges, and the need for substantial clinical trials to establish safety and efficacy. Moreover, the high costs of implementation and the complexity of integrating with existing healthcare infrastructure pose challenges. Research innovation should focus on enhancing battery life, reducing size, and improving biocompatibility. Studies on biomaterials and filtration efficiencies are promising areas for pushing technological boundaries. Additionally, exploring AI-driven monitoring systems to provide predictive analytics for personalized patient care could offer competitive advantages. The market nature is dynamic and highly competitive, with an interdisciplinary approach needed to address clinical, technological, and commercial hurdles. Companies should emphasize collaborative ventures with tech firms and clinical entities to optimize product development and expand their market footprint, addressing both technological innovations and regulatory compliance simultaneously.

KEY MARKET STATISTICS
Base Year [2023] USD 180.19 million
Estimated Year [2024] USD 213.08 million
Forecast Year [2030] USD 599.78 million
CAGR (%) 18.74%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Wearable Artificial Kidney Market

The Wearable Artificial Kidney Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of diabetes and hypertension
    • Low presence of donor, leading to limited transplantation
    • Rising awareness about various renal failure diseases, unhealthy lifestyles
  • Market Restraints
    • Stringent regulatory policies for dialysis products
  • Market Opportunities
    • Technological advancement in artificial kidney
    • Increase awareness among patients to opt for ambulatory dialysis
  • Market Challenges
    • Risk of complications of using artificial kidney

Porter's Five Forces: A Strategic Tool for Navigating the Wearable Artificial Kidney Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Wearable Artificial Kidney Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Wearable Artificial Kidney Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Wearable Artificial Kidney Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Wearable Artificial Kidney Market

A detailed market share analysis in the Wearable Artificial Kidney Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Wearable Artificial Kidney Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Wearable Artificial Kidney Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Wearable Artificial Kidney Market

A strategic analysis of the Wearable Artificial Kidney Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Wearable Artificial Kidney Market, highlighting leading vendors and their innovative profiles. These include ANSELL LTD, Asahi Kasei Medical Co., Ltd., AWAK Technologies, B. Braun, Baxter International Inc., Blood Purification Technologies Inc., Cardinal Health, Inc., Dynarex Corporation, GE Healthcare, Glove Corporation Bhd, Hartalega Holdings, Hitachi Medical Corporation, KAWASUMI LABORATORIES, INC, Koninklijke Philips N.V., Nanodialysis B.V., Semperit AG Holding, Siemens AG, and Triomed AB.

Market Segmentation & Coverage

This research report categorizes the Wearable Artificial Kidney Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Disease Stage, market is studied across Acute Renal Disease and End-Stage Renal Disease.
  • Based on Dialysis Type, market is studied across Hemodialysis and Peritoneal Dialysis.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Dialysis Centers, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of diabetes and hypertension
      • 5.1.1.2. Low presence of donor, leading to limited transplantation
      • 5.1.1.3. Rising awareness about various renal failure diseases, unhealthy lifestyles
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulatory policies for dialysis products
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement in artificial kidney
      • 5.1.3.2. Increase awareness among patients to opt for ambulatory dialysis
    • 5.1.4. Challenges
      • 5.1.4.1. Risk of complications of using artificial kidney
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Wearable Artificial Kidney Market, by Disease Stage

  • 6.1. Introduction
  • 6.2. Acute Renal Disease
  • 6.3. End-Stage Renal Disease

7. Wearable Artificial Kidney Market, by Dialysis Type

  • 7.1. Introduction
  • 7.2. Hemodialysis
  • 7.3. Peritoneal Dialysis

8. Wearable Artificial Kidney Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Dialysis Centers
  • 8.4. Hospitals

9. Americas Wearable Artificial Kidney Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Wearable Artificial Kidney Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Wearable Artificial Kidney Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. ANSELL LTD
  • 2. Asahi Kasei Medical Co., Ltd.
  • 3. AWAK Technologies
  • 4. B. Braun
  • 5. Baxter International Inc.
  • 6. Blood Purification Technologies Inc.
  • 7. Cardinal Health, Inc.
  • 8. Dynarex Corporation
  • 9. GE Healthcare
  • 10. Glove Corporation Bhd
  • 11. Hartalega Holdings
  • 12. Hitachi Medical Corporation
  • 13. KAWASUMI LABORATORIES, INC
  • 14. Koninklijke Philips N.V.
  • 15. Nanodialysis B.V.
  • 16. Semperit AG Holding
  • 17. Siemens AG
  • 18. Triomed AB

LIST OF FIGURES

  • FIGURE 1. WEARABLE ARTIFICIAL KIDNEY MARKET RESEARCH PROCESS
  • FIGURE 2. WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. WEARABLE ARTIFICIAL KIDNEY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. WEARABLE ARTIFICIAL KIDNEY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. WEARABLE ARTIFICIAL KIDNEY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. WEARABLE ARTIFICIAL KIDNEY MARKET DYNAMICS
  • TABLE 7. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY ACUTE RENAL DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-STAGE RENAL DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY PERITONEAL DIALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. WEARABLE ARTIFICIAL KIDNEY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 145. WEARABLE ARTIFICIAL KIDNEY MARKET, FPNV POSITIONING MATRIX, 2023